Sunwin Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 12 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.20 Cr
as on 24-10-2024
- Revenue 29.36%
(FY 2023)
- Profit 19.54%
(FY 2023)
- Ebitda 47.00%
(FY 2023)
- Net Worth 35.82%
(FY 2023)
- Total Assets 116.47%
(FY 2023)
About Sunwin Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹8.20 Cr.
Himank Bansal and Ranbir Bansal serve as directors at the Company.
- CIN/LLPIN
U24232HR2012PTC081658
- Company No.
081658
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panchkula, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sunwin Healthcare Private Limited offer?
Sunwin Healthcare Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Capsules, Digestive System Drugs & Medicines, Pre & Probiotic Capsule, Anti Infective Drugs & Medicines, Antibiotic Injection, Laxatives, Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Nasal Drops.
Who are the key members and board of directors at Sunwin Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Himank Bansal  | Director | 10-Jan-2015 | Current |
| Ranbir Bansal | Director | 22-Sep-2020 | Current |
Financial Performance of Sunwin Healthcare.
Sunwin Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 29.36% increase. The company also saw a substantial improvement in profitability, with a 19.54% increase in profit. The company's net worth Soared by an impressive increase of 35.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sunwin Healthcare?
In 2023, Sunwin Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 03 Jun 2024 | ₹4.99 M | Open |
Others Creation Date: 29 Jan 2024 | ₹3.00 Cr | Open |
Others Creation Date: 20 Jun 2023 | ₹3.00 Cr | Open |
How Many Employees Work at Sunwin Healthcare?
Unlock and access historical data on people associated with Sunwin Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sunwin Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunwin Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
